CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
Q2 2026Earnings receipt·reported Aug 5, 2026 · Before Open·quarter ended Jun 27, 2026
EPS Beat +11.0%Rev Beat +3.4%Stock +11.4%
The street expected
EPS consensus
$2.72
Revenue consensus
$970.8M
frozen Aug 5, 2026 — before the print erased it
The company printed
EPS (adjusted)
$3.02
GAAP ($0.03)
Revenue
$1.00B
EPS vs street
+11.0%
against $2.72 — WSE estimate desk (internal)
Revenue vs street
+3.4%
against $970.8M — WSE estimate desk (internal)
verified from the wire release · figures published 7:23 AM ET
Why this page exists
Every public surface destroys the “expected” number at the moment it matters: the actual overwrites it, and post-hoc surprise figures get computed against restated consensus. This receipt was frozen from Wall St Engine’s nightly expectation archive before the print and joined to figures verified from the release itself. It does not update, and it cannot be reconstructed after the fact.
receipt frozen 2026-08-09 10:21 UTC · actuals last refined 2026-08-09 10:38 UTC · CRL company page